{"id":"NCT02039505","sponsor":"Takeda","briefTitle":"Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis","officialTitle":"Phase III, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intravenous MLN0002 (300 mg) Infusion in Induction and Maintenance Therapy in Japanese Subjects With Moderate or Severe Ulcerative Colitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02-04","primaryCompletion":"2018-02-27","completion":"2018-06-28","firstPosted":"2014-01-17","resultsPosted":"2019-03-20","lastUpdate":"2019-04-25"},"enrollment":292,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ulcerative Colitis"],"interventions":[{"type":"DRUG","name":"Vedolizumab","otherNames":["MLN0002"]},{"type":"DRUG","name":"Vedolizumab placebo","otherNames":[]}],"arms":[{"label":"Induction Phase: Cohort 1, Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Induction Phase: Cohort 1, Vedolizumab 300 mg","type":"EXPERIMENTAL"},{"label":"Induction Phase: Cohort 2, Vedolizumab 300 mg","type":"EXPERIMENTAL"},{"label":"Maintenance Phase: Placebo","type":"EXPERIMENTAL"},{"label":"Maintenance Phase: Vedolizumab 300 mg","type":"EXPERIMENTAL"},{"label":"Maintenance Phase: Placebo continuation","type":"PLACEBO_COMPARATOR"},{"label":"Open-Label Cohort: Vedolizumab 300 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate efficacy, safety and pharmacokinetics of the vedolizumab (MLN0002) induction and maintenance therapy in Japanese participants with moderate or severe ulcerative colitis (UC).","primaryOutcome":{"measure":"Percentage of Participants With a Clinical Response at Week 10 in Induction Phase","timeFrame":"Week 10","effectByArm":[{"arm":"Induction Phase: Cohort 1, Placebo","deltaMin":32.9,"sd":null},{"arm":"Induction Phase: Cohort 1, Vedolizumab 300 mg","deltaMin":39.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2722"}]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":59,"countries":["Japan"]},"refs":{"pmids":["34409654","33454706","32635680","30807613"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":82},"commonTop":["Viral upper respiratory tract infection","Headache","Influenza","Colitis ulcerative","Upper respiratory tract infection"]}}